| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | EVP, R&D
2 companies
Tyle Praveen is an EVP, R&D at LXRX, with reported holdings spanning 2 companies. Recent filings cover 1 purchase and 0 sales. Those positions are worth an estimated $20K at current prices.
Tyle Praveen's largest disclosed position is in KPRX as Director, worth about $20K. Net of sales, the recent Form 4 record there shows accumulation of 5,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 19, 2024 | KPRX Kiora Pharmaceuticals Inc | Director | Buy | 5,000 | $3.96 | $19,800.00 | +35,714% | -20.3% | -33.9% |